 Vijaya Vemulakonda
Concepts (215)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urologic Surgical Procedures | 14 | 2022 | 94 | 4.180 |
Why?
| | Ureteral Obstruction | 6 | 2021 | 59 | 3.660 |
Why?
| | Hydronephrosis | 6 | 2021 | 30 | 2.940 |
Why?
| | Urology | 6 | 2019 | 48 | 2.170 |
Why?
| | Electronic Health Records | 6 | 2022 | 829 | 1.860 |
Why?
| | Urinary Bladder | 6 | 2022 | 180 | 1.830 |
Why?
| | Kidney Pelvis | 3 | 2021 | 21 | 1.810 |
Why?
| | Fetal Diseases | 2 | 2022 | 148 | 1.590 |
Why?
| | Renal Insufficiency | 2 | 2023 | 150 | 1.550 |
Why?
| | Vesico-Ureteral Reflux | 3 | 2022 | 21 | 1.430 |
Why?
| | Pediatrics | 4 | 2019 | 985 | 1.130 |
Why?
| | Infant | 22 | 2022 | 8293 | 1.130 |
Why?
| | Urethral Diseases | 3 | 2022 | 19 | 1.090 |
Why?
| | Kidney | 4 | 2022 | 1353 | 1.050 |
Why?
| | Decision Making | 2 | 2023 | 809 | 0.980 |
Why?
| | Urologists | 2 | 2020 | 18 | 0.880 |
Why?
| | Urethral Obstruction | 1 | 2022 | 9 | 0.870 |
Why?
| | Amniotic Fluid | 1 | 2022 | 68 | 0.870 |
Why?
| | Urinary Tract | 1 | 2022 | 40 | 0.840 |
Why?
| | Urinary Tract Infections | 3 | 2022 | 136 | 0.830 |
Why?
| | Urologic Diseases | 3 | 2018 | 36 | 0.800 |
Why?
| | Child | 30 | 2023 | 19129 | 0.800 |
Why?
| | Qualitative Research | 5 | 2022 | 953 | 0.790 |
Why?
| | Multicystic Dysplastic Kidney | 1 | 2020 | 3 | 0.780 |
Why?
| | Ultrasonography, Prenatal | 5 | 2022 | 227 | 0.770 |
Why?
| | Kidney Diseases, Cystic | 1 | 2020 | 20 | 0.770 |
Why?
| | Urinary Bladder, Neurogenic | 5 | 2022 | 32 | 0.760 |
Why?
| | Hypospadias | 2 | 2018 | 26 | 0.760 |
Why?
| | Kidney Transplantation | 2 | 2022 | 585 | 0.750 |
Why?
| | Documentation | 1 | 2022 | 175 | 0.750 |
Why?
| | Biomedical Research | 2 | 2018 | 612 | 0.740 |
Why?
| | Practice Patterns, Physicians' | 3 | 2020 | 1200 | 0.700 |
Why?
| | Fasting | 1 | 2020 | 264 | 0.670 |
Why?
| | Neurotoxicity Syndromes | 1 | 2018 | 15 | 0.670 |
Why?
| | Parents | 3 | 2023 | 1212 | 0.660 |
Why?
| | Stakeholder Participation | 1 | 2019 | 69 | 0.650 |
Why?
| | Urinary Incontinence | 2 | 2016 | 61 | 0.640 |
Why?
| | Humans | 51 | 2023 | 118972 | 0.640 |
Why?
| | Postnatal Care | 2 | 2015 | 68 | 0.630 |
Why?
| | Preoperative Care | 1 | 2020 | 332 | 0.630 |
Why?
| | Urinary Fistula | 1 | 2017 | 9 | 0.610 |
Why?
| | Outpatients | 1 | 2020 | 325 | 0.600 |
Why?
| | Prenatal Diagnosis | 2 | 2020 | 168 | 0.600 |
Why?
| | Anesthesia | 1 | 2018 | 120 | 0.580 |
Why?
| | Epispadias | 1 | 2016 | 3 | 0.580 |
Why?
| | Bladder Exstrophy | 1 | 2016 | 16 | 0.580 |
Why?
| | Urogenital Surgical Procedures | 1 | 2016 | 5 | 0.580 |
Why?
| | Clinical Decision-Making | 1 | 2019 | 278 | 0.570 |
Why?
| | Urogenital System | 1 | 2016 | 16 | 0.570 |
Why?
| | Intermittent Urethral Catheterization | 1 | 2016 | 3 | 0.570 |
Why?
| | Spinal Dysraphism | 2 | 2017 | 44 | 0.560 |
Why?
| | Kidney Failure, Chronic | 1 | 2022 | 516 | 0.560 |
Why?
| | Child, Preschool | 15 | 2022 | 9491 | 0.540 |
Why?
| | Appointments and Schedules | 2 | 2014 | 78 | 0.540 |
Why?
| | Cultural Diversity | 2 | 2022 | 55 | 0.520 |
Why?
| | Urinary Bladder Neoplasms | 2 | 2008 | 211 | 0.510 |
Why?
| | Risk Assessment | 4 | 2018 | 3057 | 0.500 |
Why?
| | Female | 30 | 2022 | 61564 | 0.500 |
Why?
| | Retrospective Studies | 17 | 2022 | 12978 | 0.490 |
Why?
| | Anus, Imperforate | 1 | 2014 | 23 | 0.480 |
Why?
| | Hernia, Umbilical | 1 | 2014 | 18 | 0.480 |
Why?
| | Urethra | 1 | 2014 | 58 | 0.460 |
Why?
| | Infant, Newborn | 8 | 2022 | 5255 | 0.460 |
Why?
| | Urogenital Abnormalities | 1 | 2014 | 48 | 0.460 |
Why?
| | Referral and Consultation | 1 | 2017 | 648 | 0.430 |
Why?
| | Wilms Tumor | 1 | 2013 | 69 | 0.430 |
Why?
| | Tumor Burden | 1 | 2013 | 274 | 0.430 |
Why?
| | Ambulatory Surgical Procedures | 1 | 2012 | 50 | 0.420 |
Why?
| | Physicians | 1 | 2020 | 794 | 0.410 |
Why?
| | Patient Selection | 1 | 2015 | 676 | 0.410 |
Why?
| | Botulinum Toxins, Type A | 3 | 2011 | 42 | 0.400 |
Why?
| | Scoliosis | 1 | 2014 | 183 | 0.400 |
Why?
| | Data Collection | 1 | 2014 | 658 | 0.390 |
Why?
| | Male | 26 | 2022 | 57801 | 0.370 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2015 | 1244 | 0.370 |
Why?
| | Pregnancy | 4 | 2022 | 5690 | 0.350 |
Why?
| | Tertiary Care Centers | 3 | 2019 | 119 | 0.350 |
Why?
| | Dextrans | 1 | 2009 | 74 | 0.340 |
Why?
| | Ultrasonography | 3 | 2021 | 716 | 0.330 |
Why?
| | Cystitis | 2 | 2005 | 21 | 0.330 |
Why?
| | Prune Belly Syndrome | 1 | 2007 | 9 | 0.320 |
Why?
| | Internship and Residency | 2 | 2008 | 1001 | 0.310 |
Why?
| | Ethics, Professional | 1 | 2007 | 15 | 0.310 |
Why?
| | Stomach Neoplasms | 1 | 2008 | 67 | 0.310 |
Why?
| | Hyaluronic Acid | 1 | 2009 | 197 | 0.300 |
Why?
| | Follow-Up Studies | 6 | 2019 | 4596 | 0.300 |
Why?
| | Diurnal Enuresis | 1 | 2006 | 1 | 0.300 |
Why?
| | Competency-Based Education | 1 | 2007 | 67 | 0.290 |
Why?
| | Professional Competence | 1 | 2007 | 91 | 0.290 |
Why?
| | Feasibility Studies | 2 | 2022 | 749 | 0.270 |
Why?
| | Adenoma | 1 | 2007 | 191 | 0.270 |
Why?
| | Databases, Factual | 3 | 2022 | 1231 | 0.270 |
Why?
| | Adolescent | 10 | 2022 | 18480 | 0.270 |
Why?
| | Biocompatible Materials | 1 | 2009 | 378 | 0.260 |
Why?
| | Neuromuscular Agents | 1 | 2005 | 31 | 0.250 |
Why?
| | Education, Medical, Graduate | 1 | 2008 | 399 | 0.240 |
Why?
| | Postoperative Complications | 4 | 2020 | 2235 | 0.240 |
Why?
| | Dissent and Disputes | 1 | 2023 | 18 | 0.240 |
Why?
| | Muscle, Smooth | 2 | 2022 | 157 | 0.230 |
Why?
| | Incidence | 3 | 2018 | 2424 | 0.230 |
Why?
| | Prospective Studies | 4 | 2020 | 6471 | 0.220 |
Why?
| | Urinary Bladder Diseases | 1 | 2022 | 20 | 0.220 |
Why?
| | Patient Care | 1 | 2023 | 105 | 0.220 |
Why?
| | Duodenum | 1 | 2022 | 67 | 0.220 |
Why?
| | Laparoscopy | 2 | 2022 | 417 | 0.220 |
Why?
| | Sexual Development | 1 | 2022 | 20 | 0.210 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2007 | 900 | 0.210 |
Why?
| | Registries | 2 | 2022 | 1810 | 0.210 |
Why?
| | Ureter | 1 | 2022 | 32 | 0.210 |
Why?
| | Postoperative Period | 2 | 2020 | 309 | 0.210 |
Why?
| | Social Justice | 1 | 2022 | 63 | 0.210 |
Why?
| | Probability | 1 | 2022 | 305 | 0.210 |
Why?
| | Urination | 3 | 2014 | 39 | 0.210 |
Why?
| | Renal Replacement Therapy | 1 | 2022 | 70 | 0.200 |
Why?
| | Urography | 2 | 2014 | 14 | 0.200 |
Why?
| | Adenocarcinoma | 1 | 2008 | 812 | 0.200 |
Why?
| | Clinical Competence | 1 | 2008 | 951 | 0.200 |
Why?
| | Ambulatory Care Facilities | 1 | 2022 | 218 | 0.190 |
Why?
| | Actins | 1 | 2022 | 404 | 0.190 |
Why?
| | Patient Portals | 1 | 2019 | 31 | 0.170 |
Why?
| | Ambulatory Care | 2 | 2022 | 482 | 0.170 |
Why?
| | User-Computer Interface | 1 | 2019 | 163 | 0.160 |
Why?
| | Bacteriuria | 1 | 2018 | 9 | 0.160 |
Why?
| | Urologic Surgical Procedures, Male | 1 | 2018 | 27 | 0.160 |
Why?
| | Social Support | 1 | 2022 | 542 | 0.160 |
Why?
| | Renal Dialysis | 1 | 2022 | 378 | 0.160 |
Why?
| | Disorders of Sex Development | 1 | 2018 | 37 | 0.160 |
Why?
| | Cohort Studies | 3 | 2017 | 5116 | 0.150 |
Why?
| | Cystostomy | 1 | 2017 | 8 | 0.150 |
Why?
| | United States | 5 | 2020 | 12555 | 0.150 |
Why?
| | Hospitals, Pediatric | 1 | 2020 | 505 | 0.150 |
Why?
| | Treatment Outcome | 4 | 2021 | 9342 | 0.150 |
Why?
| | Perioperative Care | 1 | 2018 | 132 | 0.140 |
Why?
| | Genital Diseases, Male | 1 | 2016 | 15 | 0.140 |
Why?
| | Analgesia | 1 | 2017 | 81 | 0.140 |
Why?
| | Fetus | 1 | 2020 | 690 | 0.140 |
Why?
| | Surveys and Questionnaires | 3 | 2022 | 4708 | 0.140 |
Why?
| | Global Health | 1 | 2018 | 310 | 0.140 |
Why?
| | Reoperation | 1 | 2018 | 557 | 0.140 |
Why?
| | Caregivers | 1 | 2022 | 709 | 0.140 |
Why?
| | Adult | 7 | 2022 | 31512 | 0.130 |
Why?
| | Risk Factors | 5 | 2018 | 9000 | 0.130 |
Why?
| | General Surgery | 1 | 2016 | 134 | 0.130 |
Why?
| | Health Information Exchange | 1 | 2014 | 12 | 0.120 |
Why?
| | Recovery of Function | 1 | 2018 | 604 | 0.120 |
Why?
| | ROC Curve | 1 | 2015 | 473 | 0.120 |
Why?
| | Age Factors | 3 | 2018 | 2995 | 0.120 |
Why?
| | Cloaca | 1 | 2014 | 49 | 0.120 |
Why?
| | Program Evaluation | 2 | 2008 | 845 | 0.110 |
Why?
| | Cystoscopy | 2 | 2011 | 16 | 0.100 |
Why?
| | Sex Factors | 3 | 2018 | 1781 | 0.100 |
Why?
| | Urinary Retention | 1 | 2011 | 19 | 0.100 |
Why?
| | Diagnostic Imaging | 1 | 2014 | 294 | 0.100 |
Why?
| | Severity of Illness Index | 2 | 2015 | 2674 | 0.090 |
Why?
| | Patient Compliance | 1 | 2014 | 537 | 0.090 |
Why?
| | Ureteroscopy | 1 | 2009 | 16 | 0.090 |
Why?
| | Length of Stay | 2 | 2018 | 1032 | 0.090 |
Why?
| | Injections | 1 | 2009 | 167 | 0.080 |
Why?
| | Electrocoagulation | 1 | 2007 | 36 | 0.080 |
Why?
| | Reproducibility of Results | 1 | 2015 | 2874 | 0.080 |
Why?
| | Stomach | 1 | 2008 | 103 | 0.080 |
Why?
| | Anastomosis, Surgical | 1 | 2008 | 146 | 0.080 |
Why?
| | Medical Staff, Hospital | 1 | 2007 | 76 | 0.070 |
Why?
| | Professional Role | 1 | 2007 | 153 | 0.070 |
Why?
| | Educational Measurement | 1 | 2008 | 289 | 0.070 |
Why?
| | Urothelium | 1 | 2005 | 33 | 0.070 |
Why?
| | Administration, Intravesical | 1 | 2005 | 22 | 0.070 |
Why?
| | Program Development | 1 | 2007 | 357 | 0.060 |
Why?
| | Faculty, Medical | 1 | 2007 | 252 | 0.060 |
Why?
| | Colorado | 1 | 2014 | 4196 | 0.060 |
Why?
| | Biomarkers | 1 | 2014 | 3588 | 0.060 |
Why?
| | Biopsy | 1 | 2007 | 1079 | 0.060 |
Why?
| | Phimosis | 1 | 2003 | 1 | 0.060 |
Why?
| | Tomography, X-Ray Computed | 1 | 2013 | 2436 | 0.060 |
Why?
| | Circumcision, Male | 1 | 2003 | 17 | 0.060 |
Why?
| | Adenosine Triphosphate | 1 | 2005 | 439 | 0.060 |
Why?
| | Rats, Sprague-Dawley | 2 | 2005 | 2478 | 0.050 |
Why?
| | Disease Management | 1 | 2006 | 571 | 0.050 |
Why?
| | Magnetic Resonance Imaging | 1 | 2014 | 3174 | 0.050 |
Why?
| | Chronic Disease | 2 | 2005 | 1636 | 0.050 |
Why?
| | Advisory Committees | 1 | 2022 | 212 | 0.050 |
Why?
| | Rats | 2 | 2005 | 5392 | 0.040 |
Why?
| | Urolithiasis | 1 | 2018 | 8 | 0.040 |
Why?
| | Cryptorchidism | 1 | 2018 | 12 | 0.040 |
Why?
| | Intraoperative Period | 1 | 2018 | 55 | 0.040 |
Why?
| | Stents | 1 | 2022 | 457 | 0.040 |
Why?
| | Urine | 1 | 2018 | 59 | 0.040 |
Why?
| | Colony Count, Microbial | 1 | 2018 | 120 | 0.040 |
Why?
| | Constipation | 1 | 2018 | 76 | 0.040 |
Why?
| | Young Adult | 2 | 2022 | 10793 | 0.040 |
Why?
| | Multivariate Analysis | 1 | 2018 | 1474 | 0.030 |
Why?
| | Logistic Models | 1 | 2018 | 1901 | 0.030 |
Why?
| | Quality Improvement | 1 | 2020 | 963 | 0.030 |
Why?
| | Information Storage and Retrieval | 1 | 2014 | 124 | 0.030 |
Why?
| | Anti-Bacterial Agents | 1 | 2022 | 1510 | 0.030 |
Why?
| | Quality of Life | 1 | 2022 | 2366 | 0.020 |
Why?
| | Injections, Intralesional | 1 | 2011 | 33 | 0.020 |
Why?
| | Urodynamics | 1 | 2011 | 31 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2018 | 3171 | 0.020 |
Why?
| | Lower Urinary Tract Symptoms | 1 | 2011 | 47 | 0.020 |
Why?
| | Prognosis | 1 | 2018 | 3443 | 0.020 |
Why?
| | Behavior Therapy | 1 | 2011 | 237 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2011 | 965 | 0.020 |
Why?
| | Physical Therapy Modalities | 1 | 2011 | 274 | 0.020 |
Why?
| | Combined Modality Therapy | 1 | 2011 | 1166 | 0.020 |
Why?
| | Time Factors | 1 | 2017 | 6412 | 0.020 |
Why?
| | Animals | 2 | 2005 | 33381 | 0.020 |
Why?
| | Nerve Fibers, Unmyelinated | 1 | 2005 | 9 | 0.020 |
Why?
| | Mechanoreceptors | 1 | 2005 | 14 | 0.020 |
Why?
| | Osmotic Pressure | 1 | 2005 | 32 | 0.020 |
Why?
| | Physical Stimulation | 1 | 2005 | 79 | 0.020 |
Why?
| | Cyclophosphamide | 1 | 2005 | 222 | 0.020 |
Why?
| | Sensory Receptor Cells | 1 | 2005 | 83 | 0.020 |
Why?
| | Muscle Contraction | 1 | 2005 | 413 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2005 | 3730 | 0.010 |
Why?
|
|
Vemulakonda's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|